Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ju-Wan Kim

Showing results (41-50 of 164) with videos related to

Pageof 17
Sort By:
Journal of Affective Disorders|August 10, 2021
Predictors and outcomes of experienced and anticipated discrimination in patients treated for depression: A 2-year longitudinal studyMin Jhon, Robert Stewart, Ju-Wan Kim, et al.
Frontiers in Psychiatry|February 21, 2022
Childhood Abuse, Social Support, and Long-Term Pharmacological Treatment Outcomes in Patients With Depressive DisordersJu-Yeon Lee, Robert Stewart, Hee-Ju Kang, et al.
Schizophrenia (Heidelberg, Germany)|October 4, 2023
Inflammatory markers of symptomatic remission at 6 months in patients with first-episode schizophreniaHoney Kim, Seon-Hwa Baek, Ju-Wan Kim, et al.
Psychoneuroendocrinology|September 20, 2025
Interaction between ghrelin and social support predicts antidepressant treatment outcomes in patients with depressionJae-Min Kim, Hee-Ju Kang, Ju-Wan Kim, et al.
Journal of Personalized Medicine|July 27, 2022
Association between Peripheral Inflammatory Cytokines and Cognitive Function in Patients with First-Episode SchizophreniaSeon-Hwa Baek, Honey Kim, Ju-Wan Kim, et al.
Chonnam Medical Journal|February 11, 2026
Factors Associated with Acute and Persistence of Depressive Symptoms among the General Population during the COVID-19 Pandemic in South Korea: An Online Longitudinal Survey StudyJu-Yeon Lee, Honey Kim, Ju-Wan Kim, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|October 26, 2025
Clinical Outcomes and Treatment Intensification across Depression Subtypes in Patients Receiving Stepwise Pharmacotherapy over 24 MonthsJae-Min Kim, Hee-Ju Kang, Ju-Wan Kim, et al.
The Journal of Clinical Psychiatry|July 3, 2025
Differentiating Subtypes of Major Depressive Disorder Using Serum BiomarkersJae-Min Kim, Hee-Ju Kang, Ju-Yeon Lee, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 20, 2022
Investigating associations of childhood abuse and serum brain-derived neurotrophic factor levels with suicidal behaviours in patients with depressive disordersJae-Min Kim, Ju-Wan Kim, Hee-Ju Kang, et al.
Bjpsych Open|September 16, 2025
Functional status modifies the impact of tumor necrosis factor-alpha on depression treatment responseJae-Min Kim, Hee-Ju Kang, Ju-Wan Kim, et al.
Pageof 17

Showing results (41-50 of 164) with videos related to

Sort By:
Pageof 17
Journal of Affective Disorders|August 10, 2021
Predictors and outcomes of experienced and anticipated discrimination in patients treated for depression: A 2-year longitudinal studyMin Jhon, Robert Stewart, Ju-Wan Kim, et al.
Frontiers in Psychiatry|February 21, 2022
Childhood Abuse, Social Support, and Long-Term Pharmacological Treatment Outcomes in Patients With Depressive DisordersJu-Yeon Lee, Robert Stewart, Hee-Ju Kang, et al.
Schizophrenia (Heidelberg, Germany)|October 4, 2023
Inflammatory markers of symptomatic remission at 6 months in patients with first-episode schizophreniaHoney Kim, Seon-Hwa Baek, Ju-Wan Kim, et al.
Psychoneuroendocrinology|September 20, 2025
Interaction between ghrelin and social support predicts antidepressant treatment outcomes in patients with depressionJae-Min Kim, Hee-Ju Kang, Ju-Wan Kim, et al.
Journal of Personalized Medicine|July 27, 2022
Association between Peripheral Inflammatory Cytokines and Cognitive Function in Patients with First-Episode SchizophreniaSeon-Hwa Baek, Honey Kim, Ju-Wan Kim, et al.
Chonnam Medical Journal|February 11, 2026
Factors Associated with Acute and Persistence of Depressive Symptoms among the General Population during the COVID-19 Pandemic in South Korea: An Online Longitudinal Survey StudyJu-Yeon Lee, Honey Kim, Ju-Wan Kim, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|October 26, 2025
Clinical Outcomes and Treatment Intensification across Depression Subtypes in Patients Receiving Stepwise Pharmacotherapy over 24 MonthsJae-Min Kim, Hee-Ju Kang, Ju-Wan Kim, et al.
The Journal of Clinical Psychiatry|July 3, 2025
Differentiating Subtypes of Major Depressive Disorder Using Serum BiomarkersJae-Min Kim, Hee-Ju Kang, Ju-Yeon Lee, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 20, 2022
Investigating associations of childhood abuse and serum brain-derived neurotrophic factor levels with suicidal behaviours in patients with depressive disordersJae-Min Kim, Ju-Wan Kim, Hee-Ju Kang, et al.
Bjpsych Open|September 16, 2025
Functional status modifies the impact of tumor necrosis factor-alpha on depression treatment responseJae-Min Kim, Hee-Ju Kang, Ju-Wan Kim, et al.
Pageof 17